{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:39:48Z","timestamp":1792845588412,"version":"4.5.0"},"reference-count":31,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T00:00:00Z","timestamp":1785628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Vasc Access"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>PICC-ports are emerging as an alternative long-term vascular access device in oncology. However, real-world outcome data remain limited. We evaluated device survival and complication rates in a tertiary center using a standardized bundle for PICC-port insertion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study at a tertiary vascular access center in France including 295 PICC-ports implanted in adult oncology patients between November 2023 and October 2025. Devices were inserted by anesthesiologists and specialized vascular access nurses according to the SIP-Port protocol. Data collected included demographics, cancer type, catheter dwell time, early and late complications, and device failures defined as removals due to device-related complications. Device survival was evaluated using Kaplan\u2013Meier analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 72,344 catheter-days were recorded. Mean and median device dwell times were 245.2 and 280\u2009days respectively. The cohort consisted of 138 men (46.8%) and 157 women (53.2%), with a mean age of 64.4\u2009years. The most common malignancies were breast cancer (28.1%), lung cancer (23.7%), and head and neck cancer (16.9%). Infection incidence was 0.15 per 1000 catheter-days and symptomatic catheter-related thrombosis occurred at 0.16 per 1000 catheter-days. Twenty-four devices (8.1%) were removed due to serious adverse events. Device survival free from serious adverse events at 365\u2009days was 91.2%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PICC-ports implanted by trained vascular access specialists demonstrated excellent device survival and low complication rates. These findings support the safety and reliability of PICC-ports as long-term vascular access devices for oncology patients when inserted and maintained using standardized protocols.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11297298261471393","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:39:30Z","timestamp":1785735570000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes of 295 PICC-ports implanted in cancer patients: A retrospective cohort study"],"prefix":"10.1177","author":[{"given":"Mathieu","family":"Leconte","sequence":"first","affiliation":[{"name":"Vascular Access Unit, H\u00f4pitaux du L\u00e9man, Thonon-les-Bains, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Beaufr\u00e8re","sequence":"additional","affiliation":[{"name":"Vascular Access Unit, H\u00f4pitaux du L\u00e9man, Thonon-les-Bains, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Warembourg","sequence":"additional","affiliation":[{"name":"Pharmacy, H\u00f4pitaux du L\u00e9man, Thonon-les-Bains, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubin","family":"Hillaireau","sequence":"additional","affiliation":[{"name":"Pharmacy, H\u00f4pitaux du L\u00e9man, Thonon-les-Bains, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Roziere","sequence":"additional","affiliation":[{"name":"Independent Statistician, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9313-4638","authenticated-orcid":false,"given":"Pascal","family":"Fangio","sequence":"additional","affiliation":[{"name":"Vascular Access Unit, H\u00f4pitaux du L\u00e9man, Thonon-les-Bains, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,2]]},"reference":[{"issue":"4","key":"e_1_3_3_2_2","first-page":"706","article-title":"Totally implanted venous and arterial access system to replace external catheters in cancer treatment","volume":"92","author":"Niederhuber JE","year":"1982","unstructured":"Niederhuber JE, Ensminger W, Gyves JW, et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982; 92(4): 706\u2013712.","journal-title":"Surgery"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/11297298241300792"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011883"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-019-0770-2"},{"issue":"1","key":"e_1_3_3_6_2","first-page":"338","article-title":"Retrospective evaluation of totally implantable venous access port devices: early and late complications","volume":"20","author":"Gurkan S","year":"2015","unstructured":"Gurkan S, Seber S, Gur O, et al. Retrospective evaluation of totally implantable venous access port devices: early and late complications. J BUON Off J Balk Union Oncol 2015; 20(1): 338\u2013345.","journal-title":"J BUON Off J Balk Union Oncol"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000361"},{"key":"e_1_3_3_8_2","article-title":"Comparison between arm port and chest port for optimal vascular access port in patients with breast cancer: a systematic review and meta-analysis","volume":"2020","author":"Liu Y","year":"2020","unstructured":"Liu Y, Li LL, Xu L, et al. Comparison between arm port and chest port for optimal vascular access port in patients with breast cancer: a systematic review and meta-analysis. BioMed Res Int 2020; 2020: 9082924.","journal-title":"BioMed Res Int"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14930"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S205988"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/11297298231209521"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2020.02.028"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-022-01317-7"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.5301\/jva.5000609"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/11297298221136330"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-024-01608-z"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/11297298211067683"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/1129729819884482"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2017.11.059"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/1129729819894461"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/599376"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/jan.13766"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/11297298251317296"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.46268\/jsu.2021.8.2.48"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70266-4"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/1129729818758999"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2011.06.016"},{"issue":"3","key":"e_1_3_3_28_2","first-page":"180","article-title":"Guidelines for the management of intravascular catheter-related infections","volume":"24","author":"Mermel LA","year":"2001","unstructured":"Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs 2001; 24(3): 180\u2013205.","journal-title":"J Intraven Nurs"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.4065\/81.9.1159"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2022.31.8.S4"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0119-2018"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-005-1711-y"}],"container-title":["The Journal of Vascular Access"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11297298261471393","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11297298261471393","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11297298261471393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:48:51Z","timestamp":1792842531000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11297298261471393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,2]]},"references-count":31,"alternative-id":["10.1177\/11297298261471393"],"URL":"https:\/\/doi.org\/10.1177\/11297298261471393","relation":{},"ISSN":["1129-7298","1724-6032"],"issn-type":[{"value":"1129-7298","type":"print"},{"value":"1724-6032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,2]]},"article-number":"11297298261471393"}}